Currently predicting for Mon, 1 Apr 2024

Trading levels for XBIO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.25 6.70 %
R2 4.17 4.68 %
R1 4.12 3.44 %
Current price: 3.98
Support S1 3.96 -0.592 %
S2 3.91 -1.84 %
S3 3.83 -3.85 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.35 9.30 %
R2 4.07 2.26 %
R1 4.05 1.76 %
Current price 3.98
Support S1 3.95 -0.754%
S2 3.84 -3.52%
S3 3.66 -8.04%

XBIO Predictions History

2 years ago
Rybkarybka predicted that XBIO for 2021-11-01 is going $1.75 (-1.13%)

2 years ago
JS predicted that XBIO for 2021-10-28 is going

2 years ago
Rybkarybka predicted that XBIO for 2021-10-28 is going $1.74 (3.57%)

2 years ago
Rybkarybka predicted that XBIO for 2021-10-15 is going $1.94 (7.78%)

2 years ago
JS predicted that XBIO for 2021-10-12 is going $2.00 (4.71%)

2 years ago
Rybkarybka predicted that XBIO for 2021-10-12 is going $2.22 (16.23%)

2 years ago
Rybkarybka predicted that XBIO for 2021-10-11 is going $2.01 (5.79%)

2 years ago
JS predicted that XBIO for 2021-10-07 is going $1.92 (3.78%)

2 years ago
Rybkarybka predicted that XBIO for 2021-10-07 is going $1.96 (5.95%)

2 years ago
Rybkarybka predicted that XBIO for 2021-10-05 is going $2.00 (9.29%)

Click to get the best stock tips daily for free!

About Xenetic Biosciences Inc

Xenetic Biosciences Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor ... XBIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT